— Know what they know.
Not Investment Advice

4480.T JPX

Medley, Inc.
1W: -1.8% 1M: -17.4% 3M: +14.1% YTD: -3.4% 1Y: -27.4% 3Y: -55.7% 5Y: -51.0%
¥2,307.00 ($14.62)
-16.00 (-0.69%)
 
Weekly Expected Move ±4.2%
¥2115 ¥2211 ¥2307 ¥2403 ¥2499
JPX · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 36 · ¥69.3B mcap · 20M float · 1.24% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥69.3B ($439.2M)
52W Range1715-3040
Volume201,100
Avg Volume242,851
Beta0.80
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOKohei Takiguchi
Employees1,511
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2019-12-12
Websitemedley.jp
Roppongi Hills Mori Tower
Tokyo 106-6113
JP
+81 3 6331 5511
About Medley, Inc.

Medley, Inc., a company based in Japan, develops and manages digital platforms for both the recruitment and medical industries. Its operations are structured into three primary segments: HR Platform Business, Medical Platform Business, and New Services. The firm's portfolio of offerings includes JobMedley, a human resources recruitment system specifically for medical, healthcare, and related sectors; CLINICS Telemedicine, a system enabling virtual consultations between patients and healthcare providers; CLINICS, a cloud-based platform for medical facility support; Pharms, which provides support systems for pharmacy front-desk operations; MEDLEY, a service offering medical information to patients; and Kaigo-no Honne, an online portal for searching nursing care facilities. Additionally, Medley, Inc. undertakes proof-of-concept testing for its Pharms solutions. The company was established in 2009 and maintains its corporate headquarters in Tokyo, Japan.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms